Discussion
To our knowledge, this study is one of the largest series of vulvar LP. The percentage of LP that we found in our clinic is slightly higher than that described in similar series, reinforcing that this vulvar dermatosis is not as rare as previously thought.13 To put in perspective, the rate of lichen sclerosus in our clinic, a more frequent and well-known dermatosis, is 21.9%.
Our data confirms previous findings in terms of patients’ characteristics and clinical presentation.14 Regarding therapeutic decisions, a quarter of our patients needed a second line treatment for disease control and 6.3% needed more than two therapeutic options before experiencing an improvement in their symptoms. The schemes of ultra-potent topical corticosteroid used are similar to the ones described in the literature.15